News

The FDA approved risankizumab in June for adult patients with Crohn’s disease, representing the first IL-23 treatment to be approved for this patient population.

Microperimetry was safe and appeared predictive, detecting in at least 65% of cases the risk of AMD.

Officials with the US Preventive Services Task Force have new recommendations for adult mental health screens.

Concurrent metabolic syndrome was independently linked to a worse overall and recurrence-free survival rates.

LX9211 is a potent, orally delivered, selective small molecule inhibitor of adaptor-associated kinase 1 (AAK1).

Brolucizumab use in treatment-naive and previously anti-VEGF-treated patients with nAMD was linked to improvements in visual acuity, CST, IRF and SRF.

Despite worldwide trend data, incidence trends for dermatomyositis do not show increases among the study population.

Short and long nighttime sleep duration, along with daytime napping, were associated with a moderate increase in risk of cardiovascular diseases.

Simon Walsh, MD, and Elizabeth Estes join Lungcast to discuss advancements in biomarker and treatment option deliberation for the rare disease through data.

The genus most consistently associated with Crohn’s disease was Fusobacterium, but disease-associated genera were mostly inconsistent between studies.

In the group positive for HCV by RNA testing in the emergency department, the linkage to care was just 44.1%, compared to 67.6% for patients in outpatient clinics and 50.9% for patients in inpatient units.

A recent study in China aligns with findings regarding lower life quality rankings for older adults.

Evidence has suggested a relationship between screen time and poor sleep among youth, however, little evidence has been provided for adults.

Dr. Thosani discusses the convergence of technology and physiology, treatment advancements, and virtual medicine capabilities in the field of heart arrhythmia.

A reduction in aspirin use was associated with significantly less bleeding and health care use, without an increase in thrombotic outcomes.

Research upholds prior recommendations for treating younger patients hospitalized with influenza.

Mother's who follow the DASH dietary pattern experience better sleep health for themselves and their infants, according to new study.

When compared to traditional in-lab polysomnography, the Circul ring-worn oximeter produced similarly reliable results in detecting obstructive sleep apnea (OSA).

Study data suggest HbA1c level from diabetes diagnosis is a strong biomarker for PDR and nephropathy, with the prevalence of both increasing more than 30 years after diagnosis.

High CPAP adherence also resulted in a significant protective effect on the 30-day readmission for beneficiaries with heart failure.

Patients with IBD were approximately 3.5 times more likely to have moderate or severe periodontitis.

New EADV data suggest clinicians may need to uniquely treat patients with adult-onset eczema based on inflammatory pathways.

The approval is based on data from 2 clinical trials showing the agent improved the rate of post-operation patients avoiding sickness by 50%.

A draft report released from the Institute for Clinical and Economic Review (ICER) compared the benefits of etranacogene dezaparvovec (EtranaDez) and valoctocogene roxaparvovec (val-rox) to current treatments.

New data, alongside any future research operating from a family systems approach can provide novel insight into sleep, mental health, and attachments.

Lifestyle interventions increased weight-specific quality of life in Latino youth with diabetes compared with usual care.

Children regularly engaged in physical activities had significantly better visual and stereoacuity than those who reported moderate, light or no activity.

The inter-relationship of HPCs, HSCs, and macrophages was influenced by the stage of fibrosis, but not BMI.

The increase in EoE incidence was most pronounced in men and for patients aged 40 years and older.

In this episode of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, provide a recap of the European Society of Cardiology Congress 2022. This recap begins with a discussion on the results of the phase 3 DELIVER trial, in which Vaduganathan served as an investigator, the ADVOR trial, and REVIVED.